Literature DB >> 4862069

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4862069

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  236 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Reflections on the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  S G Sheps; E J Roccella
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 3.  Vasopeptidase inhibition: a new direction in cardiovascular treatment.

Authors:  J R Asher; A J Naftilan
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 4.  Progress in the 1980s and new directions in the 1990s with hypertension management. From the stepped-care approach to the individualised programme in hypertension treatment and control.

Authors:  H Pardell; P Armario; R Hernández
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 5.  Explanatory models are needed to integrate RCT and observational data with the patient's unique biology.

Authors:  Vijay Sharma; Rubin Minhas
Journal:  J R Soc Med       Date:  2012-01       Impact factor: 5.344

Review 6.  Under pressure: the search for the essential mechanisms of hypertension.

Authors:  Thomas M Coffman
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 7.  Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

Authors:  Michael F O'Rourke; Audrey Adji; Mayooran Namasivayam; Jonathan Mok
Journal:  Drugs Aging       Date:  2011-10-01       Impact factor: 3.923

8.  Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

Authors:  J S Yudkin; B Richter; E A M Gale
Journal:  Diabetologia       Date:  2010-08-05       Impact factor: 10.122

9.  Peripheral renal vascular disease in essential hypertension: hemodynamic, angiographic, and endocrine assessment.

Authors:  I P Arlart; J Rosenthal
Journal:  Cardiovasc Intervent Radiol       Date:  1984       Impact factor: 2.740

10.  Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.

Authors:  A Lehtonen; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.